Medpace Holdings Inc vs Motorola Solutions Inc — how do they compare? Medpace Holdings Inc trades at $530.32 (market cap $15.08B), while Motorola Solutions Inc trades at $407.18 (market cap $68.13B). The key difference: Motorola Solutions Inc is far larger — about 4.5× Medpace Holdings Inc's market cap, and Motorola Solutions Inc pays a 1.18% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | MSI | |
|---|---|---|
Market Cap | $15.08B | $68.13B |
Sector | Technology | Technology |
52-Week High | $620.59 | $490.30 |
52-Week Low | $308.88 | $363.83 |
Enterprise Value | $14.55B | $76.83B |
Dividend Yield | — | 1.18% |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
MSI trades at $412.34, down 0.23% on the day, with a neutral technical signal. The company shows strong profitability with a 17.61% net income margin and has beaten earnings estimates for three consecutive quarters. Recent developments include the $1.5 billion acquisition of D-Fend Solutions and expansion of AI capabilities for emergency response systems, indicating strategic growth in public safety technology.
The outlook remains positive with a consensus price target of $512.33, representing 24% upside potential. Key risks include high valuation multiples and significant investing cash outflows from acquisitions. Analyst sentiment is bullish with 70.59% buy ratings, though investors should monitor integration execution of recent deals and competitive pressures in the tech sector.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →